Volume 37, Issue 2 pp. 119-125

Antioxidant Effects of Dehydroepiandrosterone Are Related to Up-regulation of Thioredoxin in SH-SY5Y Cells

Jing GAO

Corresponding Author

Jing GAO

School of Medicine, School of Life Sciences, Nanjing University, Nanjing 210093, China;

*Corresponding author: Tel, 86-25-83593374; Fax, 86-25-83686559; E-mail, [email protected]Search for more papers by this author
Hui-Ying SUN

Hui-Ying SUN

School of Medicine, School of Life Sciences, Nanjing University, Nanjing 210093, China;

Search for more papers by this author
Zeng-Rong ZHU

Zeng-Rong ZHU

School of Medicine, School of Life Sciences, Nanjing University, Nanjing 210093, China;

Search for more papers by this author
Zhen DING

Zhen DING

School of Medicine, School of Life Sciences, Nanjing University, Nanjing 210093, China;

Search for more papers by this author
Li ZHU

Li ZHU

Institute of Nautical Medicine, Nantong University, Nantong 226001, China

Search for more papers by this author
First published: 09 February 2005
Citations: 1

Abstract

Abstract Neuroprotective effects of dehydroepiandrosterone (DHEA) have been shown to be associated with its antioxidant properties, but the mechanisms remain unknown. Considering that the thioredoxin (Trx) system, an important cellular redox modulation system, changes under oxidative stress and could exert protective effects, the relationship between the antioxidant effects of DHEA and the Trx system regulation was explored. Using MTT assay and morphological observation, the effects of DHEA in the model of H2O2-induced oxidative stress in SH-SY5Y cells were analyzed, then RT-PCR and Western blot assay were used to detect the alteration in mRNA and protein level of Trx. The results showed that a pre-treatment of DHEA (10–100 nM) protected cells against the toxicity induced by H2O2 in a dose-dependent manner, which could be confirmed in morphological observation by phase-contract microscope. In addition, Trx mRNA transcription was inhibited by H2O2 (300 μM), which could be reversed by the pre-administration of DHEA in various concentrations (0.1–100 nM). Western blot assay confirmed that protein level of Trx could be elevated by the pre-treatment of DHEA (10–100 nM) with the exposure of H2O2. Taken together, these data suggest that DHEA may be useful in treating age-related neurodegenerative diseases based on its up-regulating effects on an antioxidant and neuroprotective protein thioredoxin, a substrate in the Trx redox system.

Edited by Bao-Lu ZHAO

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.